US 12,390,529 B2
Stable infusion solution composition containing sugar and amino acid
Geon Moo Lee, Gwangju (KR); In Seong Lee, Gwangju (KR); Jun Seong Lee, Gwangju (KR); and Mi Boon Chung, Seoul (KR)
Appl. No. 17/265,858
Filed by Geon Moo Lee, Gwangju (KR); In Seong Lee, Gwangju (KR); Jun Seong Lee, Gwangju (KR); and Mi Boon Chung, Seoul (KR)
PCT Filed Jul. 24, 2019, PCT No. PCT/KR2019/009200
§ 371(c)(1), (2) Date Feb. 4, 2021,
PCT Pub. No. WO2020/032439, PCT Pub. Date Feb. 13, 2020.
Claims priority of application No. 10-2018-0091284 (KR), filed on Aug. 6, 2018.
Prior Publication US 2021/0170030 A1, Jun. 10, 2021
Int. Cl. A61K 47/26 (2006.01); A61K 9/08 (2006.01); A61K 47/18 (2017.01); A61K 47/40 (2006.01)
CPC A61K 47/26 (2013.01) [A61K 9/08 (2013.01); A61K 47/183 (2013.01); A61K 47/40 (2013.01)] 2 Claims
 
1. An Infusion solution composition comprising:
one or more amino acids selected from the group consisting of 20 amino acids capable of constituting a protein;
glucose, galactose, mannose, fucose, xylose, N-acetylglucosamine, N-acetylgalactosamine and N-acetylneuraminic acid; and
a stabilizer,
wherein the stabilizer is one or more selected from the group consisting of β-cyclodextrin and aminoguanidine.